Chang Ming-Ling, Yeh Chau-Ting, Chang Pei-Yeh, Chen Jeng-Chang
Liver Research Unit, Department of Hepatogastroenterology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, China.
World J Gastroenterol. 2005 Jul 21;11(27):4167-72. doi: 10.3748/wjg.v11.i27.4167.
To build up the research models of hepatic fibrosis in mice.
Inbred wild-type FVB/N mice were either treated with alpha-naphthyl-isothiocyanate (ANIT), allyl alcohol (AA), carbon tetrachloride (CCl(4)), 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), and silica, or subjected to common bile duct ligation (CBDL) to induce hepatic injury. Liver biopsies were performed every 4 wk to evaluate hepatic fibrosis over a period of 6 mo. Cumulative cirrhosis and survival curves were constructed by life table method and compared with Wilcoxon test.
Under the dosages used, there was neither mortality nor cirrhosis in AA and silica-treated groups. DDC and ANIT caused cirrhosis within 4-12 and 12-24 wk, respectively. Both showed significantly faster cirrhosis induction at high dosages without significant alteration of survival. The duration for cirrhosis induction by CCl(4) ranged from 4 to 20 wk, mainly dependent upon the dosage. However, the increase in CCl(4) dosage significantly worsened survival. Intraperitoneal CCl(4) administration resulted in better survival in comparison with gavage administration at high dosage, but not at medium and low dosages. After CBDL, all the mice developed liver cirrhosis within 4-8 wk and then died by the end of 16 wk.
CBDL and administrations of ANIT, CCl(4), and DDC ensured liver cirrhosis. CBDL required the least amount of time in cirrhosis induction, but caused shortened lives of mice. It was followed by DDC and ANIT administration with favorable survival. As for CCl(4), the speed of cirrhosis induction and the mouse survival depended upon the dosages and the administration route.
建立小鼠肝纤维化研究模型。
将近交野生型FVB/N小鼠分别用α-萘异硫氰酸酯(ANIT)、烯丙醇(AA)、四氯化碳(CCl₄)、3,5-二乙氧羰基-1,4-二氢可力丁(DDC)和二氧化硅处理,或进行胆总管结扎(CBDL)以诱导肝损伤。每4周进行一次肝活检,在6个月的时间内评估肝纤维化情况。通过生命表法构建累积肝硬化和生存曲线,并与Wilcoxon检验进行比较。
在所使用的剂量下,AA和二氧化硅处理组既无死亡也无肝硬化发生。DDC和ANIT分别在4 - 12周和12 - 24周内导致肝硬化。两者在高剂量时均显示出明显更快的肝硬化诱导速度,且生存率无显著改变。CCl₄诱导肝硬化的持续时间为4至20周,主要取决于剂量。然而,CCl₄剂量的增加显著降低了生存率。与高剂量灌胃给药相比,腹腔注射CCl₄可提高生存率,但中低剂量时并非如此。CBDL后,所有小鼠在4 - 8周内发展为肝硬化,然后在16周结束时死亡。
CBDL以及ANIT、CCl₄和DDC给药均可导致肝硬化。CBDL诱导肝硬化所需时间最短,但会缩短小鼠寿命。其次是DDC和ANIT给药,生存率良好。至于CCl₄,肝硬化诱导速度和小鼠生存率取决于剂量和给药途径。